SCHEMBL25979616

SCHEMBL25979616

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc4c(c3)oc3cc(N(c5ccc6c(c5)oc5ccccc56)c5ccc6c(c5)oc5ccccc56)ccc34)n2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHR P35869 2/20 0.41
MAPT P10636 7/20 0.41
ALDH1A1 P00352 6/20 0.41
HPGD P15428 6/20 0.41
KMT2A Q03164 5/20 0.41
KDM4E B2RXH2 4/20 0.41
MEN1 O00255 4/20 0.41
HCRTR1 O43613 1/20 0.39
LMNA P02545 3/20 0.38
TSHR P16473 3/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
CYP3A4 P08684 2/20 0.38
TTR P02766 1/20 0.38
CYP1A2 P05177 1/20 0.38
GLA P06280 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
RECQL P46063 1/20 0.38
HIF1A Q16665 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25979515 0.97 AHR (0.40) AHRMAPTALDH1A1HPGDKMT2A
SCHEMBL25979910 0.96 AHR (0.39) AHRMAPTALDH1A1HPGDKMT2A
SCHEMBL25978862 0.96 MAPT (0.39) AHRMAPTALDH1A1HPGDKMT2A
SCHEMBL24255832 0.96 AHR (0.41) AHRMAPTALDH1A1HPGDKMT2A
SCHEMBL26571587 0.96 AHR (0.41) AHRMAPTALDH1A1HPGDKMT2A
SCHEMBL25979705 0.95 MMP12 (0.40) AHRMAPTALDH1A1HPGDKMT2A
SCHEMBL21117093 0.94 AHR (0.41) AHRMAPTALDH1A1HPGDKMT2A
SCHEMBL26779206 0.94 MAPT (0.37) AHRMAPTALDH1A1HPGDKMT2A
SCHEMBL25978774 0.94 MAPT (0.37) AHRMAPTALDH1A1HPGDKMT2A
SCHEMBL24255837 0.93 AHR (0.41) AHRMAPTALDH1A1HPGDKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230365538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2023-11-16 US disclosed
US-20230365538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2023-11-16 US disclosed
EP-4227301-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT Materials Co., Ltd. (KR) 2023-08-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230365538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY1, CYP1A1, CYP1B1 AHR 21/4885MAPT 1428/4885ALDH1A1 9/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.